Cannabis Stocks Flashing Buy After Worst Week Of Year

Analysis originally distributed on November 23, 2016 By: Michael Vodicka of Cannabis Stock Trades

If anyone thought investing in weed stock was going to be easy, this week was a reality check.

Cannabis stocks collided with two obstacles in the last week.

The first, four of the largest Canadian medical marijuana stocks were temporarily halted because of high levels of volatility.

For example, last Wednesday Canopy Growth Corp (CGC) was surging into a new all-time high above $17 – up more than 20% on the day.

While that was great news for shareholders, it set off the Toronto Stock Exchanges (TSE) circuit breaker. Shares were temporarily halted so the exchange engines wouldn’t melt down like a hunk of warm cheese.

Aphria (APH), the second-largest Canadian medical marijuana company, and Organigram (OGI), the third-largest Canadian medical marijuana company, were also halted last week after hitting new all-time highs.

The trading halts only lasted a few minutes at a time.

However, damage was inflicted. Continue reading "Cannabis Stocks Flashing Buy After Worst Week Of Year"

Canadian Cannabis Stocks are Surging

Analysis originally distributed on November 16, 2016 By: Michael Vodicka of Cannabis Stock Trades

It’s been a tale of two markets for cannabis stocks.

On one hand, U.S. cannabis stocks have struggled since eight U.S. states approved new marijuana programs last Tuesday.

For example, industry leader Terra Tech (TRTC) is down 18% in the last five days. Kush Bottles (KSHB) is down 35%.

On the other, Canadian cannabis stocks have been killing it.

Canopy Growth Corp (CGC), the largest medical marijuana company in Canada is up 74% in the last week. Aphria (APH) is up 51%. Organigram (OGI) is up 46%.

Chart of Canopy Growth Corp.

Chart courtesy of StockCharts.com

This has a lot of cannabis investors scratching their heads.

After all, didn’t the U.S. market just see a big wave of legalization? Continue reading "Canadian Cannabis Stocks are Surging"

Cannabis Industry Bats 88% As 8 Out Of 9 States Vote Yes

Analysis originally distributed on November 10, 2016 By: Michael Vodicka of Cannabis Stock Trades

The results are in. November 8, 2016 will go down in history as a great day for the legal cannabis industry and the world.

Nine U.S. states had medical and recreational marijuana programs on the ballot. From those nine states, eight have voted yes.

On the recreational side, four out of five states have approved new initiatives.

  • California: passed
  • Massachusetts: passed
  • Nevada: passed
  • Maine: passed
  • Arizona: failed

As you can see this list includes California, the world’s largest marijuana market.

On the medical side, all four states voted yes.

  • Florida: passed
  • Arkansas: passed
  • Nevada: passed
  • North Dakota: passed
  • Montana: passed

Florida looked like a huge baller this election cycle.

Not only did it virtually decide the presidential election as a key swing state, it also decided to throw another log on the fire and legalized medical marijuana for good measure.

These results mark a watershed moment for the legal cannabis industry. I expect these additional legalizations to serve as a huge catalyst for the industry.

On January 1, 2017, 29 states, more than half the country, will have medical and recreational programs in place.

That will create new jobs, increase tax revenue and decrease crime.

I also expect it to be a powerful catalyst for marijuana stocks. Continue reading "Cannabis Industry Bats 88% As 8 Out Of 9 States Vote Yes"

3 Little-Known Cannabis Stocks Beating the S&P 500 by at Least 1,000% in 2016

We could not be more excited to share this post from Micheal Vodicka of Cannabis Stock Trades!

Cannabis Stock Trades is an exciting new site that will help traders profit from the explosive legal cannabis industry. Cannabis Stock Trades is powered by INO.com.


The U.S. economy is in a funk.

Second-quarter gross domestic product (GDP), the broadest indicator of economic strength, clocked in at just 1.1%, well below expectations of 2.4%.

In economics, 1.1% GDP growth is the equivalent of “holding your nose just above water.”

In the meantime, the S&P 500 is mired in a nasty earnings recession. Earnings have now declined for the last five quarters. The last time that happened was in 2009 during the financial crisis.

The weak economy has created a dilemma. Investors are desperately searching for growth.

I've got the solution. Continue reading "3 Little-Known Cannabis Stocks Beating the S&P 500 by at Least 1,000% in 2016"

Should You Invest In Marijuana Stocks?

By: Andy Obermueller of Street Authority

Let me start off by saying that today's essay is not for everyone. But as Chief Investment Strategist for Game-Changing Stocks, it's my job to bring readers the best aggressive growth investing opportunities the market has to offer.

If it just so happens to come from an industry that some find morally objectionable, then so be it.

But I received a question from a subscriber the other day that I know many of our readers have been wondering about: Should I invest in marijuana stocks? If so, which ones should I be looking at? Continue reading "Should You Invest In Marijuana Stocks?"